Skip to main content

Table 2 Predictors of comfort, interest, training and knowledge of prescribing GAHT

From: Primary care provider beliefs and knowledge of prescribing gender-affirming hormone therapy to transgender and gender diverse patients

 

PCP age:

 

#Years in practice

 

Practice setting

 

Group

age \(\le\) 41

age  ≥42

p-value†

0–10 years

 > 10 years

p-value†

Non-academic

Academic

p-value†

% comfortable prescribing GAHT (n)

67% (123)

49% (97)

0.009*

65% (130)

51% (90)

0.037*

64% (179)

41% (41)

0.013*

% answered positively re: learning more about GAHT (n)

89% (123)

63% (97)

 < 0.001*

86% (130)

66% (90)

< 0.001*

76% (179)

78% (41)

0.683

% answered positively re: interest in prescribing GAHT (n)

74% (123)

46% (97)

 < 0.001*

70% (130)

50% (90)

0.003*

63% (179)

59% (41)

0.722

% answered positively re: the benefit of GME on GAHT (n)

89% (123)

82% (97)

0.242

87% (130)

84% (90)

0.694

85% (179)

86% (41)

1.00

% answered positively re: benefit of CME on GAHT (n)

87% (123)

81% (97)

0.267

85% (130)

85% (90)

1.00

83% (179)

85% (41)

0.811

   

p-value‡

  

p-value‡

  

p-value‡

Correctly answered knowledge questions (n)

1.4 (123)

1.7 (97)

0.033*

1.4 (130)

1.7 (90)

0.09

1.4 (179)

2 (41)

0.002*

  1. *statistically significant p-value
  2. Fisher’s Exact test p-value
  3. T-test p-value